Overview
VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness
Status:
Completed
Completed
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine the safety and efficacy of VSF-173 compared to placebo in treatment of induced excessive sleepiness.Phase:
Phase 2Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Vanda Pharmaceuticals
Criteria
Inclusion Criteria:- Healthy subjects with no medical, psychiatric, or current sleep disorders
- Subject must sign a written consent form
Exclusion Criteria:
- Evidence of excessive daytime sleepiness
- History of sleep disorders
- Psychiatric or neurological disorders